Arginine deprivation, growth inhibition and tumour cell death: 3. Deficient utilisation of citrulline by malignant cells
2003

Arginine Deprivation and Tumor Cell Death

Sample size: 11 publication Evidence: moderate

Author Information

Author(s): Wheatley D N, Campbell E

Primary Institution: University of Aberdeen

Hypothesis

Can citrulline supplementation rescue tumor cells from arginine deprivation?

Conclusion

The study found that many tumor cell lines are unable to utilize citrulline effectively, making them vulnerable to arginine deprivation therapies.

Supporting Evidence

  • 80% of tumor cell lines die when arginine is removed from their environment.
  • Some melanoma cell lines cannot be rescued by citrulline but can grow with argininosuccinate.
  • Half of the tumor cell lines studied were deficient in argininosuccinate synthetase.

Takeaway

Some cancer cells can't use a helper molecule called citrulline when they run out of another molecule called arginine, which means we might be able to starve them to stop their growth.

Methodology

The study involved culturing various tumor cell lines in arginine-free medium and assessing their ability to utilize citrulline and argininosuccinate.

Limitations

The study only examined a small sample of cell lines and did not explore all tumor types.

Participant Demographics

The study included various human and murine tumor cell lines.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6601134

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication